Clincosm LogoSign in Get a demo

Unresectable Solid Neoplasm

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, HIV Infection, Metastatic Malignant Solid Tumor Trial in United States (Cabozantinib S-malate,

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Cabozantinib S-malate
  • +2 more
  • La Jolla, California
  • +19 more
Dec 14, 2022

Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Ipilimumab
  • Nivolumab
  • La Jolla, California
  • +34 more
Nov 29, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • CDK Inhibitor AT7519
  • +3 more
  • Washington, District of Columbia
  • +5 more
Oct 18, 2022

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

Active, not recruiting
  • BRAF NP_004324.2:p.V600X
  • +6 more
  • Cetuximab
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Phoenix, Arizona
  • +14 more
Sep 1, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem

Completed
  • Metastatic Malignant Neoplasm in the Brain
  • +11 more
  • Laboratory Biomarker Analysis
  • siRNA-transfected Peripheral Blood Mononuclear Cells APN401
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (GNX102)

Recruiting
  • Solid Tumor
  • +3 more
  • Los Angeles, California
  • +5 more
Mar 7, 2022

Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

Active, not recruiting
  • Adult Solid Neoplasm
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in Houston (Nivolumab)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Solid Neoplasm
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 1, 2021

Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in

Completed
  • Advanced Malignant Solid Neoplasm
  • +24 more
  • Oxidative Phosphorylation Inhibitor IACS-010759
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2020

Advanced Solid Tumor, Aggressive Non-Hodgkin Lymphoma, Recurrent Solid Tumor Trial in Chicago (other, biological, drug)

Unknown status
Has Results
  • Advanced Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Chicago, Illinois
    Northwestern University
Oct 27, 2020

Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma, Metastatic Malignant Solid

Withdrawn
  • Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Feb 6, 2020

Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

Withdrawn
  • Advanced Malignant Solid Neoplasm
  • +17 more
  • Glembatumumab Vedotin
  • +4 more
  • (no location specified)
Jul 17, 2018